127 related articles for article (PubMed ID: 4095360)
1. [New method for the determination of estrogen and progesterone receptors in human breast cell lines].
Olea N; Devleeschower N; Leclercq G
Rev Esp Fisiol; 1985 Dec; 41(4):373-80. PubMed ID: 4095360
[TBL] [Abstract][Full Text] [Related]
2. Estrone receptor formation during the processing of estradiol-receptor complex in MCF-7 cells.
Hansen ER; Brooks SC
Cancer Res; 1982 May; 42(5):1967-74. PubMed ID: 7066908
[TBL] [Abstract][Full Text] [Related]
3. Assay for estrogen and progesterone receptors of breast cancer cell lines in monolayer culture.
Olea-Serrano N; Devleeschouwer N; Leclercq G; Heuson JC
Eur J Cancer Clin Oncol; 1985 Aug; 21(8):965-73. PubMed ID: 4043179
[TBL] [Abstract][Full Text] [Related]
4. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells.
Reiner GC; Katzenellenbogen BS; Bindal RD; Katzenellenbogen JA
Cancer Res; 1984 Jun; 44(6):2302-8. PubMed ID: 6547074
[TBL] [Abstract][Full Text] [Related]
5. Effect of Org OD14 (LIVIAL) and its metabolites on human estrogen sulphotransferase activity in the hormone-dependent MCF-7 and T-47D, and the hormone-independent MDA-MB-231, breast cancer cell lines.
Chetrite GS; Kloosterboer HJ; Philippe JC; Pasqualini JR
Anticancer Res; 1999; 19(1A):269-75. PubMed ID: 10226553
[TBL] [Abstract][Full Text] [Related]
6. Effects of Org OD14 (Livial) and its metabolites on 17 beta-hydroxysteroid dehydrogenase activity in hormone-dependent MCF-7 and T-47D breast cancer cells.
Chetrite GS; Kloosterboer HJ; Philippe JC; Pasqualini JR
Anticancer Res; 1999; 19(1A):261-7. PubMed ID: 10226552
[TBL] [Abstract][Full Text] [Related]
7. Binding characteristics and biological activity of 17 alpha-[125I]iodovinyl-11 beta-methoxyestradiol, an estrogen receptor-binding radiopharmaceutical, in human breast cancer cells (MCF-7).
McManaway ME; Jagoda EM; Eckelman WC; Larson SM; Francis BE; Gibson RE; Reba RC; Lippman ME
Cancer Res; 1986 May; 46(5):2386-9. PubMed ID: 3697981
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of an estrogen-inhibited variant derived from the MCF-7 breast cancer cell line.
Bronzert DA; Triche TJ; Gleason P; Lippman ME
Cancer Res; 1984 Sep; 44(9):3942-51. PubMed ID: 6744309
[TBL] [Abstract][Full Text] [Related]
9. Characterization and assay of progesterone receptor in human mammary carcinoma.
Pichon MF; Milgrom E
Cancer Res; 1977 Feb; 37(2):464-71. PubMed ID: 832270
[TBL] [Abstract][Full Text] [Related]
10. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
Miller MA; Lippman ME; Katzenellenbogen BS
Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
[TBL] [Abstract][Full Text] [Related]
11. Non-steroid receptor-mediated antiproliferative activity of styrylpyrone derivative in human breast cancer cell lines.
Pihie AH; Stanslas J; Din LB
Anticancer Res; 1998; 18(3A):1739-43. PubMed ID: 9673398
[TBL] [Abstract][Full Text] [Related]
12. [Metastatic breast cancers: comparison of the prognostic significance and the sensitivity to chemotherapy according to the presence of estradiol and progesterone receptors].
Pouillart P; Madgelenat H; Jouve M; Palangie T; Garcia-Giralt E; Bretaudeau B; Polijcak M; Asselain B
Bull Cancer; 1982; 69(5):461-7. PubMed ID: 7165808
[TBL] [Abstract][Full Text] [Related]
13. Failure of estradiol immunofluorescence in MCF-7 breast cancer cells to detect estrogen receptors.
Mercer WD; Edwards DP; Chamness GC; McGuire WL
Cancer Res; 1981 Nov; 41(11 Pt 1):4644-52. PubMed ID: 7030480
[TBL] [Abstract][Full Text] [Related]
14. The anti-aromatase effect of progesterone and of its natural metabolites 20alpha- and 5alpha-dihydroprogesterone in the MCF-7aro breast cancer cell line.
Pasqualini JR; Chetrite G
Anticancer Res; 2008; 28(4B):2129-33. PubMed ID: 18751385
[TBL] [Abstract][Full Text] [Related]
15. Correlation of lactogenic receptor concentration in human breast cancer with estrogen receptor concentration.
Murphy LJ; Murphy LC; Vrhovsek E; Sutherland RL; Lazarus L
Cancer Res; 1984 May; 44(5):1963-8. PubMed ID: 6324992
[TBL] [Abstract][Full Text] [Related]
16. Reduction of estrogen receptor concentration in MCF-7 human breast carcinoma cells following exposure to chemotherapeutic drugs.
Yang KP; Samaan NA
Cancer Res; 1983 Aug; 43(8):3534-8. PubMed ID: 6861126
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels.
Fitzpatrick SL; Brightwell J; Wittliff JL; Barrows GH; Schultz GS
Cancer Res; 1984 Aug; 44(8):3448-53. PubMed ID: 6331648
[TBL] [Abstract][Full Text] [Related]
18. Growth inhibition by progestins in a human endometrial cancer cell line with estrogen-independent progesterone receptors.
Terakawa N; Hayashida M; Shimizu I; Ikegami H; Wakimoto H; Aono T; Tanizawa O; Matsumoto K; Nishida M
Cancer Res; 1987 Apr; 47(7):1918-23. PubMed ID: 3815380
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric determination of estrogen receptors in intact cells.
Oxenhandler RW; McCune R; Subtelney A; Truelove C; Tyrer HW
Cancer Res; 1984 Jun; 44(6):2516-23. PubMed ID: 6722791
[TBL] [Abstract][Full Text] [Related]
20. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
